UPL, FMC Corp collaborate for Rynaxypyr active ingredient

Image
Capital Market
Last Updated : Mar 02 2021 | 11:16 AM IST

Don't want to miss the best from Business Standard?

The long-term strategic collaboration provides UPL access in key markets prior to patent expiration, to commercialize FMC Corporation's leading insecticide, Rynaxypyr active.

As per the agreement, UPL will toll manufacture and supply Rynaxypyr to FMC in India, and FMC will supply the active ingredient to UPL depending on the markets. The deal adds a key portfolio of products to UPL's business and supports FMC in maximizing the penetration of this important active ingredient.

Rynaxypyr is considered a reduced risk pesticide due to its favourable toxicological and environmental profile. It is a useful tool for farmers in integrated pest management systems. This provides opportunities for growers to implement more sustainable solutions, supporting UPL's mission to make every single food product more sustainable.

"We are very excited to work with FMC on this mutually beneficial agreement. The collaboration clearly demonstrates our commitment to our OpenAg Purpose to create an agriculture network that feeds sustainable growth for all," said Jai Shroff, Global CEO of UPL. "Early access to Rynaxypyr formulations in key markets allows UPL to provide growers with more sustainable product choices," according to Diego Casanello, COO of UPL. "This agreement enables us to add a new core active ingredient to our portfolio and to develop a new family of innovative, high-value solutions for farmers."

"We are pleased to engage in this strategic relationship with UPL, adding a new global partner to our diamide growth strategy," said Mark Douglas, FMC president and chief executive officer. "This is an important collaboration for FMC to expand our leading diamide technology in diverse geographies and crops with differentiated formulations. FMC has continued to grow the diamides significantly since acquiring them in late 2017, including achieving double-digit year-on-year growth again in 2020. We forecast the diamide franchise will continue to grow above market rates, and our strategic partners are an important component in that growth."

On a consolidated basis, UPL reported a 12.6% jump in net profit to Rs 944 crore on 2.6% rise in net sales to Rs 9,126 crore in Q3 FY21 over Q3 FY20.

Shares of UPL lost 0.53% to Rs 587.10 on BSE. UPL is a global provider of sustainable agriculture products & solutions.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 02 2021 | 10:14 AM IST

Next Story